Funding announced for revolutionary technology projects.

Funding has been announced for 12 projects with companies from the south Connemara (IRL) as partners in four of those projects.

Leagan Gaeilge

Tomás Ó Síocháin, Chief Executive of Údarás na Gaeltachta, has welcomed the announcement that three of the authority's client companies - Eirecomposites, HiTech Health Manufacturing and InverMed (all based not far from The Read-out Signpost location) are partners in projects which will receive a share of the Disruptive Technologies Innovation Fund.

This morning the Minister for Enterprise, Trade and Employment, Simon Coveney T.D., the Minister for Higher and Further Education, Research, Innovation and Science, Simon Harris, T.D. and the Minister of State for Trade Promotion, Digital and Company Regulation, Dara Calleary T.D. announced an allocation of €58.8 million for proposals under the Disruptive Technologies Innovation Fund (DTIF). The aim of the fund is to support investment in the development and deployment of disruptive technologies and applications on a commercial basis.

Eirecomposites, based in Indreabhán, is a partner in the NSPCCA project, which is developing communication methods and satellites in space, jointly with the University of Ireland, Dublin, the company Mbryonics in Galway and other parties. Funding of almost €8 million has been announced for them today.

Eirecomposites, together with the University of Galway and Microfocus Galway Ltd, is also involved in the Digi-Stent project, which has received funding of €4 million, to create wireless digital stents.

HiTech Health Manufacturing has received €6.5m to develop CellConnect, a project that will capture data from every stage of the cell manufacturing process; the Gaeltacht company, located at An Tulach, is collaborating with the University of Galway and with Odyssey Validation Consultants Ltd.

Selio System, a pre-biopsy intervention device, has also received €4 million; Inver Med, based in Indreabhán, is jointly involved in this project with Trinity College, the University of Limerick and Selio Medical Ltd.

"This is great news for the companies involved in the projects that received funding today. It it notable that a company from the Conamara Gaeltacht is involved in a third of the groundbreaking projects which have been recognised as exceptional." said Tomás Ó Síocháin of the Údarás. "This is a great achievement for the companies themselves and also for this small Gaeltacht area. It shows that companies in Gaeltacht regions can be on a par with pioneering companies in Ireland and around the world, if they emphasize constant innovation, research and development."

"Our sincere congratulations to Eirecomposites, InverMed and HiTech Health Manufacturing. Údarás na Gaeltachta aims to ensure that the Gaeltacht is at the cutting edge of innovation; there are other companies emerging across the Gaeltacht regions, which will be just as creative and innovative as the ones we recognise today, and we at Údarás na Gaeltachta will be there to assist them."

---

The area in Ireland where Irish is spoken as a vernacular is known as "The Gaeltacht" 

 @UdarasnaG #Ireland

Maoiniú fógraithe do thograí ardtheicneolaíochta.

Fógraíodh maoiniú do 12 togra agus tá comhlachtaí as deisceart Chonamara mar pháirtnéirí in gceithre cinn de na tograí 

sin.

Tá fáilte curtha ag Údarás na Gaeltachta roimh an bhfógra go bhfuil trí cinn de chliaint chomhlachtaí an Údaráis - Eirecomposites, Déantúsaíocht Sláinte HiTech agus InverMed - ag fáil sciar den chiste DTIF do theicneolaíochtaí bun-athraitheacha.

English  Version

D’fhógair an tAire Fiontair, Trádála agus Fostaíochta, Simon Coveney T.D., an tAire do Ard agus Breis Oideachas, Taighde, Nuálaíocht agus Eolaíochta, Simon Harris, T.D. agus an tAire Stáit do Chur chun Cinn Trádála, Digiteach agus Rialaithe Comhlachta, Dara Calleary T.D. , allúntas €58.8 milliún do thograí faoin gCiste do Theicneolaíocht Bhunathraitheach agus Nuálaíocht (DTIF) inné. Is ciste maoinithe é seo a thacaíonn le infheistíocht i dteicneolaíochtaí athraitheacha agus ina bhforbairt le gur féidir iad a úsáid ar bhonn tráchtála.

Tá Eirecomposites, atá lonnaithe in Indreabhán, mar pháirtnéir sa togra NSPCCA, atá ag forbairt modhanna cumarsáide agus satailítí sa spás, i gcomhpháirt le hOllscoil na hÉireann, Baile Átha Cliath, an comhlacht Mbryonics i nGaillimh agus páirtithe eile. Tá maoiniú de bheagnach €8 milliún fógartha dóibh inniu.

Tá Eirecomposites mar pháirtí freisin sa togra Digi-Stent, a bhfuil maoiniú de €4 mhilliún faighte aige, chun feistí leighis digiteacha a chruthú, i gcomhair le hOllscoil na Gaillimhe agus Microfocus Galway Ltd.

Tá €6.5m faighte ag an gcomhlacht Déantúsaíocht Sláinte HiTech, chun forbairt a dhéanamh ar CellConnect, togra a bhailíonn sonraí faoi chealla ón gcéad nóiméad a gcruthaítear iad; tá an comhlacht seo, atá lonnaithe ar Pháirc Ghnó na Tulaigh, mar pháirtnéir sa togra le hOllscoil na Gaillimhe agus le comhlacht i gCill Dara, Odyssey Validation Consultants Ltd.

Tá €4 milliún faighte freisin ag an togra leighis Selio System, a bhfuil Inver Med, atá lonnaithe in Indreabhán páirteach ann, i gcomhpháirt le Coláiste na Tríonóide, Ollscoil Luimnigh agus Selio Medical Ltd.

“Is iontach an scéal é seo do na comhlachtaí atá páirteach sna tograí a fuair maoiniú inniu agus is díol bróid don Údarás go bhfuil comhlacht as Gaeltacht Chonamara páirteach san tríú cuid de na tograí a fuair maoiniú," a dúirt Tomás Ó Síocháin, Príomhfheidhmeannach Údarás na Gaeltachta

“Is éacht í do na comhlachtaí féin agus éacht don cheantar beag Gaeltachta seo. Is cruthúnas é freisin gur féidir le comhlachtaí i gceantair Gaeltachta a bheith chomh maith le comhlachtaí in aon áit eile sa tír nó ar fud na cruinne, má bhíonn béim acu ar an nuálaíocht, ar an taighde agus ar an bhforbairt leanúnach.”

“Déanann muid comhghairdeachas ó chroí le Eirecomposites, le InverMed agus le Déantúsaíocht Sláinte HiTech. Is í an aidhm atá againn, go mbeadh an Ghaeltacht ceannródaíoch i gcúrsaí nuálaíochta agus cruthaitheachta. Tá mé cinnte go bhfuil comhlachtaí eile ag teacht chun cinn ar fud na Gaeltachta atá chomh cruthaitheach agus chomh nuálaíoch céanna leis na comhlachtaí atá ag fáil aitheantais inniu, agus beidh muidne in Údarás na Gaeltachta faoi réir le cabhrú leo. “

---

@UdarasnaG @EireComposites @HealthHitech @DeptEnterprise @OllnaGaillimhe #disruptive #Health #Éire

Displays for augmented reality (AR) glasses.

MICLEDI Microdisplays, an imec spin-off, has raised €4,5M seed capital from imec.xpand, with participation of PMV and FIDIMEC. The funding will be used to develop microLED displays for next generation Augmented Reality (AR) glasses.

MICLEDI’s vision is to enable AR for everyday personal use - smart glasses that are small, lightweight, with long battery life, and at reasonable cost. To make this happen, MICLEDI is developing the world smallest and brightest displays. The key innovation behind MICLEDI is the new integration technology for microLED on 300mm wafers developed in collaboration with imec.

L-r: Dr. Soeren Steudel, co-founder and CTO; Dr. Alexander Mityashin, co-founder and COO; Seán Lord, CEO

MICLEDI Microdisplays was founded by Dr. Soeren Steudel and Dr. Alexander Mityashin, both researchers from imec with a deep know-how in the R&D field and display development. They are joined by Seán Lord, an experienced executive in the semiconductor industry, as CEO.

“AR glasses may replace our smartphones in the future and display technology is a key enabler for such a transition. Today’s display technologies cannot fulfil the specifications needed for next generation AR glasses. At MICLEDI we are tackling this challenge and have developed displays that are 100x brighter than commercial alternatives” - explains Soeren Steudel, co-founder of MICLEDI.

In order to implement the vision that future consumer AR devices will be powered by a tiny display developed in Leuven, the company has raised a 4.5M euro seed investment from imec.xpand, PMV, and FIDIMEC.

“We are pleased to back a unique team. We look forward to working with them and to enable technology that will be at the core of future AR devices and will change how digital information is presented to consumers” – says Cyril Vančura, Partner at imec.xpand.

MICLEDI’s will develop its microLED technology and first prototypes on imec’s 300mm pilot-line infrastructure.

“Hardware development takes courage, capital and time. We are proud of the entrepreneurship of our engineers to bring promising technology developments originating from our R&D, to the market” says Luc Van den hove, president and CEO at imec. “Based on an original concept launched, now more than 2 years ago, by the MICLEDI team, imec together with imec.xpand incubated this into a promising technology base and exciting business case. It leverages imecs extensive R&D in organic displays, 300mm integration and wafer-scale optics technologies.”

“MICLEDI’s new generation displays for AR glasses fits in PMV’s strategy of supporting early stage technology with a largescale international potential, hence strengthening Flander’s position as a top region.” – Roald Borré, Head of Equity Investments at PMV.

#Research @imec_int